Lex

Tale of two chairs at Novartis

Daniel Vasella will be honorary chairman at Novartis even as the Swiss drugs group gets a new chairman. Lex's Stuart Kirk and Vincent Boland discuss the potential for conflict and how Novartis has mishandled Mr Vasella's departure.